CeriBell, Inc (CBLL) support and resistance · rev $65.4M
CeriBell, Inc (CBLL) is a medical devices company listed on US.
This page maps CeriBell, Inc (CBLL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
CBLL currently screens at market cap $768.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CBLL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CBLL quote page for the session range and the stock page for the full model.
Not investment advice.